Semble, a healthcare management platform for outpatient providers, has raised £30 million in a Series C round led by Revaia, with participation from Partech, Mercia Ventures and Octopus Ventures. The funding will be used to expand into the largest healthcare groups, advance its position as an AI orchestration layer for care delivery, and strengthen its presence in France.
Founded to address the lack of coordination in healthcare, Semble helps outpatient providers coordinate care and manage the entire patient journey. More than 10 million patients - around 1 in 6 people in the United Kingdom - have received care from a clinician using the platform. Trusted by over 1,700 healthcare businesses across 80 specialities and used daily by 16,000 professionals, customers include Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality and ProblemShared.
Healthcare providers across the United Kingdom and Europe are facing mounting operational pressure caused by fragmented technology systems, rising patient demand and a generational shift towards private medical insurance and self-pay care models. As one of the most widely adopted systems for managing private healthcare in the United Kingdom, Semble is seeing strong momentum among providers seeking to consolidate fragmented operational systems into unified platforms.
The platform integrates with over 1,200 external tools across diagnostics, billing, labs, CRM and more. Since December 2024, headcount has grown by over 50%, and the integrations and partnerships ecosystem has expanded accordingly. In France, Semble's open, flexible platform has demonstrated significant regulatory maturity in less than a year. Named by TIME as one of the World's Top HealthTech Companies for 2025, Semble plans to use the funding to further its ambition of becoming the AI care orchestration layer underpinning modern healthcare delivery across Europe.
For years, the industry has tried to address complex systemic issues through disconnected point solutions, but fragmented technology often adds operational complexity for healthcare providers and creates an interrupted experience for patients. What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.
Semble is building the system of action for modern healthcare - a platform with genuine clinical depth, real scale and the trust of healthcare providers across the UK and France. The European healthcare market is being reshaped - by technology, by demand and by shifting patient expectations - and Semble is exceptionally well positioned to lead it. Revaia is proud to back the company with the investment further strengthening its conviction in the long-term transformation of healthcare.
